ID   HEMO_HUMAN              Reviewed;         462 AA.
AC   P02790; B2R957;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   18-JUN-2025, entry version 220.
DE   RecName: Full=Hemopexin;
DE   AltName: Full=Beta-1B-glycoprotein;
DE   Flags: Precursor;
GN   Name=HPX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2842511; DOI=10.1007/bf02138368;
RA   Altruda F., Poli V., Restagno G., Silengo L.;
RT   "Structure of the human hemopexin gene and evidence for intron-mediated
RT   evolution.";
RL   J. Mol. Evol. 27:102-108(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-462.
RX   PubMed=3220477; DOI=10.1016/0888-7543(88)90158-9;
RA   Law M.L., Cai G.Y., Hartz J.A., Jones C., Kao F.T.;
RT   "The hemopexin gene maps to the same location as the beta-globin gene
RT   cluster on human chromosome 11.";
RL   Genomics 3:48-52(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 22-462.
RX   PubMed=2989777; DOI=10.1093/nar/13.11.3841;
RA   Altruda F., Poli V., Restagno G., Argos P., Cortese R., Silengo L.;
RT   "The primary structure of human hemopexin deduced from cDNA sequence:
RT   evidence for internal, repeating homology.";
RL   Nucleic Acids Res. 13:3841-3859(1985).
RN   [5]
RP   PROTEIN SEQUENCE OF ACTIVE PROTEIN.
RX   PubMed=3855550; DOI=10.1073/pnas.82.1.73;
RA   Takahashi N., Takahashi Y., Putnam F.W.;
RT   "Complete amino acid sequence of human hemopexin, the heme-binding protein
RT   of serum.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:73-77(1985).
RN   [6]
RP   PROTEIN SEQUENCE OF 24-255.
RX   PubMed=6510521; DOI=10.1016/0014-5793(84)80603-1;
RA   Frantikova V., Borvak J., Kluh I., Moravek L.;
RT   "Amino acid sequence of the N-terminal region of human hemopexin.";
RL   FEBS Lett. 178:213-216(1984).
RN   [7]
RP   PARTIAL PROTEIN SEQUENCE, AND GLYCOSYLATION AT THR-24; ASN-64; ASN-64;
RP   ASN-187; ASN-240; ASN-246 AND ASN-453.
RX   PubMed=6371807; DOI=10.1073/pnas.81.7.2021;
RA   Takahashi N., Takahashi Y., Putnam F.W.;
RT   "Structure of human hemopexin: O-glycosyl and N-glycosyl sites and unusual
RT   clustering of tryptophan residues.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:2021-2025(1984).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-453.
RC   TISSUE=Bile;
RX   PubMed=15084671; DOI=10.1074/mcp.m400015-mcp200;
RA   Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H., Thuluvath P.J.,
RA   Argani P., Goggins M.G., Maitra A., Pandey A.;
RT   "A proteomic analysis of human bile.";
RL   Mol. Cell. Proteomics 3:715-728(2004).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187; ASN-240 AND ASN-246.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-64 AND ASN-187.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-453.
RC   TISSUE=Saliva;
RX   PubMed=16740002; DOI=10.1021/pr050492k;
RA   Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T., Loo J.A.;
RT   "Identification of N-linked glycoproteins in human saliva by glycoprotein
RT   capture and mass spectrometry.";
RL   J. Proteome Res. 5:1493-1503(2006).
RN   [12]
RP   INTERACTION WITH HEPATITIS E VIRUS/HEV ORF3 PROTEIN (MICROBIAL INFECTION).
RX   PubMed=18211098; DOI=10.1021/bi7016552;
RA   Ratra R., Kar-Roy A., Lal S.K.;
RT   "The ORF3 protein of hepatitis E virus interacts with hemopexin by means of
RT   its 26 amino acid N-terminal hydrophobic domain II.";
RL   Biochemistry 47:1957-1969(2008).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-187 AND ASN-453.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   GLYCOSYLATION AT ASN-187 AND ASN-453.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT THR-24; ASN-64; ASN-187 AND
RP   ASN-453, AND STRUCTURE OF CARBOHYDRATES.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E., Brinkmalm G.,
RA   Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [16]
RP   INTERACTION WITH FLVCR1.
RX   PubMed=20610401; DOI=10.1074/jbc.m110.119131;
RA   Yang Z., Philips J.D., Doty R.T., Giraudi P., Ostrow J.D., Tiribelli C.,
RA   Smith A., Abkowitz J.L.;
RT   "Kinetics and specificity of feline leukemia virus subgroup C receptor
RT   (FLVCR) export function and its dependence on hemopexin.";
RL   J. Biol. Chem. 285:28874-28882(2010).
RN   [17]
RP   GLYCOSYLATION AT THR-29, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23234360; DOI=10.1021/pr300963h;
RA   Halim A., Ruetschi U., Larson G., Nilsson J.;
RT   "LC-MS/MS characterization of O-glycosylation sites and glycan structures
RT   of human cerebrospinal fluid glycoproteins.";
RL   J. Proteome Res. 12:573-584(2013).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Binds heme and transports it to the liver for breakdown and
CC       iron recovery, after which the free hemopexin returns to the
CC       circulation.
CC   -!- SUBUNIT: Interacts with FLVCR1. {ECO:0000269|PubMed:20610401}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with hepatitis E virus/HEV
CC       protein ORF3. {ECO:0000269|PubMed:18211098}.
CC   -!- INTERACTION:
CC       P02790; Q8IXK2: GALNT12; NbExp=3; IntAct=EBI-1223791, EBI-8995375;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
CC   -!- PTM: N- and O-glycosylated. O-glycosylated with core 1 or possibly core
CC       8 glycans. O-glycosylation in the 30-40 region is minor compared to
CC       glycosylation at Thr-24 and Thr-29. {ECO:0000269|PubMed:14760718,
CC       ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:16740002, ECO:0000269|PubMed:19139490,
CC       ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19838169,
CC       ECO:0000269|PubMed:23234360, ECO:0000269|PubMed:6371807}.
CC   -!- MISCELLANEOUS: The isolated N-terminal domain binds one heme. The full-
CC       length protein also binds one heme, but at a different site. The
CC       physiological significance of this is not clear (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the hemopexin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA26382.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M36803; AAA58678.1; -; Genomic_DNA.
DR   EMBL; M36796; AAA58678.1; JOINED; Genomic_DNA.
DR   EMBL; M36799; AAA58678.1; JOINED; Genomic_DNA.
DR   EMBL; M36800; AAA58678.1; JOINED; Genomic_DNA.
DR   EMBL; M36801; AAA58678.1; JOINED; Genomic_DNA.
DR   EMBL; M36802; AAA58678.1; JOINED; Genomic_DNA.
DR   EMBL; AK313648; BAG36404.1; -; mRNA.
DR   EMBL; J03048; AAA52704.1; -; mRNA.
DR   EMBL; X02537; CAA26382.1; ALT_INIT; mRNA.
DR   CCDS; CCDS7763.1; -.
DR   PIR; I56456; OQHU.
DR   RefSeq; NP_000604.1; NM_000613.3.
DR   AlphaFoldDB; P02790; -.
DR   SASBDB; P02790; -.
DR   SMR; P02790; -.
DR   BioGRID; 109500; 78.
DR   DIP; DIP-38339N; -.
DR   FunCoup; P02790; 505.
DR   IntAct; P02790; 46.
DR   MINT; P02790; -.
DR   STRING; 9606.ENSP00000265983; -.
DR   DrugBank; DB00080; Daptomycin.
DR   DrugBank; DB14533; Zinc chloride.
DR   DrugBank; DB14548; Zinc sulfate, unspecified form.
DR   CarbonylDB; P02790; -.
DR   GlyConnect; 757; 84 N-Linked glycans (5 sites), 3 O-Linked glycans (2 sites).
DR   GlyCosmos; P02790; 10 sites, 109 glycans.
DR   GlyGen; P02790; 12 sites, 226 N-linked glycans (5 sites), 9 O-linked glycans (6 sites).
DR   iPTMnet; P02790; -.
DR   PhosphoSitePlus; P02790; -.
DR   BioMuta; HPX; -.
DR   DMDM; 1708182; -.
DR   REPRODUCTION-2DPAGE; IPI00022488; -.
DR   CPTAC; non-CPTAC-1131; -.
DR   jPOST; P02790; -.
DR   MassIVE; P02790; -.
DR   PaxDb; 9606-ENSP00000265983; -.
DR   PeptideAtlas; P02790; -.
DR   PRIDE; P02790; -.
DR   ProteomicsDB; 51598; -.
DR   Pumba; P02790; -.
DR   Antibodypedia; 23841; 566 antibodies from 40 providers.
DR   DNASU; 3263; -.
DR   Ensembl; ENST00000265983.8; ENSP00000265983.3; ENSG00000110169.12.
DR   GeneID; 3263; -.
DR   KEGG; hsa:3263; -.
DR   MANE-Select; ENST00000265983.8; ENSP00000265983.3; NM_000613.3; NP_000604.1.
DR   UCSC; uc001mdg.3; human.
DR   AGR; HGNC:5171; -.
DR   CTD; 3263; -.
DR   DisGeNET; 3263; -.
DR   GeneCards; HPX; -.
DR   HGNC; HGNC:5171; HPX.
DR   HPA; ENSG00000110169; Tissue enriched (liver).
DR   MIM; 142290; gene.
DR   neXtProt; NX_P02790; -.
DR   OpenTargets; ENSG00000110169; -.
DR   PharmGKB; PA29441; -.
DR   VEuPathDB; HostDB:ENSG00000110169; -.
DR   eggNOG; KOG1565; Eukaryota.
DR   GeneTree; ENSGT00390000009178; -.
DR   HOGENOM; CLU_061713_0_0_1; -.
DR   InParanoid; P02790; -.
DR   OMA; CSSAMRW; -.
DR   OrthoDB; 8953614at2759; -.
DR   PAN-GO; P02790; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; P02790; -.
DR   TreeFam; TF331201; -.
DR   PathwayCommons; P02790; -.
DR   Reactome; R-HSA-2168880; Scavenging of heme from plasma.
DR   SignaLink; P02790; -.
DR   SIGNOR; P02790; -.
DR   BioGRID-ORCS; 3263; 9 hits in 1149 CRISPR screens.
DR   ChiTaRS; HPX; human.
DR   GeneWiki; Hemopexin; -.
DR   GenomeRNAi; 3263; -.
DR   Pharos; P02790; Tbio.
DR   PRO; PR:P02790; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P02790; protein.
DR   Bgee; ENSG00000110169; Expressed in right lobe of liver and 106 other cell types or tissues.
DR   ExpressionAtlas; P02790; baseline and differential.
DR   GO; GO:0072562; C:blood microparticle; HDA:UniProtKB.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; HDA:BHF-UCL.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:MGI.
DR   GO; GO:0015232; F:heme transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042168; P:heme metabolic process; IBA:GO_Central.
DR   GO; GO:0015886; P:heme transport; TAS:ProtInc.
DR   GO; GO:0020027; P:hemoglobin metabolic process; IEA:Ensembl.
DR   GO; GO:0006879; P:intracellular iron ion homeostasis; TAS:ProtInc.
DR   GO; GO:0002925; P:positive regulation of humoral immune response mediated by circulating immunoglobulin; IEA:Ensembl.
DR   GO; GO:0002639; P:positive regulation of immunoglobulin production; IEA:Ensembl.
DR   GO; GO:0060335; P:positive regulation of type II interferon-mediated signaling pathway; IEA:Ensembl.
DR   GO; GO:0051246; P:regulation of protein metabolic process; IEA:Ensembl.
DR   GO; GO:0060333; P:type II interferon-mediated signaling pathway; IEA:Ensembl.
DR   CDD; cd00094; HX; 2.
DR   FunFam; 2.110.10.10:FF:000009; Hemopexin; 1.
DR   FunFam; 2.110.10.10:FF:000013; Hemopexin; 1.
DR   Gene3D; 2.110.10.10; Hemopexin-like domain; 2.
DR   InterPro; IPR051298; Heme_transport/Cell_adhesion.
DR   InterPro; IPR016358; Hemopexin.
DR   InterPro; IPR000585; Hemopexin-like_dom.
DR   InterPro; IPR036375; Hemopexin-like_dom_sf.
DR   InterPro; IPR018487; Hemopexin-like_repeat.
DR   InterPro; IPR018486; Hemopexin_CS.
DR   PANTHER; PTHR22917:SF9; HEMOPEXIN; 1.
DR   PANTHER; PTHR22917; HEMOPEXIN DOMAIN-CONTAINING PROTEIN; 1.
DR   Pfam; PF00045; Hemopexin; 5.
DR   PIRSF; PIRSF002551; Hemopexin_chordata; 1.
DR   SMART; SM00120; HX; 5.
DR   SUPFAM; SSF50923; Hemopexin-like domain; 2.
DR   PROSITE; PS00024; HEMOPEXIN; 2.
DR   PROSITE; PS51642; HEMOPEXIN_2; 8.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Heme;
KW   Host-virus interaction; Iron; Metal-binding; Proteomics identification;
KW   Reference proteome; Repeat; Secreted; Signal; Transport.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000269|PubMed:3855550,
FT                   ECO:0000269|PubMed:6510521"
FT   CHAIN           24..462
FT                   /note="Hemopexin"
FT                   /evidence="ECO:0000269|PubMed:3855550"
FT                   /id="PRO_0000021406"
FT   REPEAT          53..93
FT                   /note="Hemopexin 1"
FT   REPEAT          94..139
FT                   /note="Hemopexin 2"
FT   REPEAT          140..184
FT                   /note="Hemopexin 3"
FT   REPEAT          185..231
FT                   /note="Hemopexin 4"
FT   REPEAT          259..304
FT                   /note="Hemopexin 5"
FT   REPEAT          305..352
FT                   /note="Hemopexin 6"
FT   REPEAT          357..396
FT                   /note="Hemopexin 7"
FT   REPEAT          400..450
FT                   /note="Hemopexin 8"
FT   REGION          29..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          30..40
FT                   /note="O-glycosylated at one site"
FT   COMPBIAS        38..48
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         79
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="1"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250"
FT   BINDING         150
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="1"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250"
FT   BINDING         236
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="2"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250"
FT   BINDING         293
FT                   /ligand="heme"
FT                   /ligand_id="ChEBI:CHEBI:30413"
FT                   /ligand_label="2"
FT                   /ligand_part="Fe"
FT                   /ligand_part_id="ChEBI:CHEBI:18248"
FT                   /note="axial binding residue"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        24
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:19838169,
FT                   ECO:0000269|PubMed:6371807, ECO:0000269|PubMed:6510521"
FT   CARBOHYD        29
FT                   /note="O-linked (GalNAc...) threonine"
FT                   /evidence="ECO:0000269|PubMed:23234360"
FT   CARBOHYD        64
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19838169, ECO:0000269|PubMed:6371807"
FT   CARBOHYD        187
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14760718,
FT                   ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:16740002, ECO:0000269|PubMed:19139490,
FT                   ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19838169,
FT                   ECO:0000269|PubMed:6371807"
FT   CARBOHYD        240
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14760718,
FT                   ECO:0000269|PubMed:6371807, ECO:0000269|PubMed:6510521"
FT   CARBOHYD        246
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:14760718,
FT                   ECO:0000269|PubMed:6371807, ECO:0000269|PubMed:6510521"
FT   CARBOHYD        453
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:15084671,
FT                   ECO:0000269|PubMed:16740002, ECO:0000269|PubMed:19139490,
FT                   ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19838169,
FT                   ECO:0000269|PubMed:6371807"
FT   DISULFID        50..231
FT                   /evidence="ECO:0000269|PubMed:3855550"
FT   DISULFID        149..154
FT                   /evidence="ECO:0000269|PubMed:3855550"
FT   DISULFID        188..200
FT                   /evidence="ECO:0000269|PubMed:3855550"
FT   DISULFID        257..460
FT                   /evidence="ECO:0000269|PubMed:3855550"
FT   DISULFID        366..408
FT                   /evidence="ECO:0000269|PubMed:3855550"
FT   DISULFID        418..435
FT                   /evidence="ECO:0000269|PubMed:3855550"
FT   VARIANT         52
FT                   /note="D -> N (in dbSNP:rs10839564)"
FT                   /id="VAR_047137"
FT   VARIANT         83
FT                   /note="R -> W (in dbSNP:rs12117)"
FT                   /id="VAR_033990"
FT   CONFLICT        411
FT                   /note="K -> R (in Ref. 2; BAG36404)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   462 AA;  51676 MW;  054B44D0603763B8 CRC64;
     MARVLGAPVA LGLWSLCWSL AIATPLPPTS AHGNVAEGET KPDPDVTERC SDGWSFDATT
     LDDNGTMLFF KGEFVWKSHK WDRELISERW KNFPSPVDAA FRQGHNSVFL IKGDKVWVYP
     PEKKEKGYPK LLQDEFPGIP SPLDAAVECH RGECQAEGVL FFQGDREWFW DLATGTMKER
     SWPAVGNCSS ALRWLGRYYC FQGNQFLRFD PVRGEVPPRY PRDVRDYFMP CPGRGHGHRN
     GTGHGNSTHH GPEYMRCSPH LVLSALTSDN HGATYAFSGT HYWRLDTSRD GWHSWPIAHQ
     WPQGPSAVDA AFSWEEKLYL VQGTQVYVFL TKGGYTLVSG YPKRLEKEVG TPHGIILDSV
     DAAFICPGSS RLHIMAGRRL WWLDLKSGAQ ATWTELPWPH EKVDGALCME KSLGPNSCSA
     NGPGLYLIHG PNLYCYSDVE KLNAAKALPQ PQNVTSLLGC TH
//
